Comprehensive advisory on tax, audit, incentives, transfer pricing and financial reporting processes in the highly regulated healthcare and pharmaceutical sectors.
Industry risks
Key areas of risk
We assess tax, audit, social security and operational compliance in the context of your industry.
Regulatory and compliance risk
Failure to adapt promptly to changes in health authority requirements, reimbursement institutions, public procurement processes and pharmaceutical regulations may lead to financial and operational sanctions.
Transfer pricing risk
Failure to structure licensing, R&D, distribution, royalty and service fees on an arm’s length basis within multinational pharmaceutical and medical device groups creates significant tax audit risks.
VAT and incentive application risk
Incorrect management of different VAT rates, exemptions and incentives relating to medical devices, pharmaceuticals, clinical research and healthcare services may affect cash flow and tax liabilities.
Revenue recognition and contract risk
Public procurement, distributor agreements, reimbursement models, performance-based sales terms and promotional practices may complicate financial reporting.
Data security and personal data risk
Weaknesses in protecting patient data, clinical trial records and commercially sensitive information may have legal, reputational and financial consequences.
Common needs
The needs businesses encounter
Industry-specific tax compliance and planning
Comprehensive tax advisory is required to properly manage sector-specific exemptions, deductions, incentives, documentation, VAT and withholding tax.
Independent audit and financial reporting
It is important to prepare financial statements in accordance with local standards or IFRS/TFRS and reliably audit inventories, revenue, provisions and reimbursement processes.
Transfer pricing documentation
Defensible transfer pricing policies should be established for licensing, royalties, intragroup services, R&D, distribution and supply chain transactions.
Internal control and process improvement
Strengthening controls in procurement, inventory, quality, tenders, sales, collections and distributor management reduces operational losses.
Incentive and R&D advisory
Identifying appropriate incentive mechanisms for clinical research, product development, digital health, manufacturing investments and technology transfer provides a competitive advantage.